Skip to main content
OpenTrials

Clinical trial condition

Acquired Resistance to KRAS G12C Inhibitor

Explore clinical trials studying Acquired Resistance to KRAS G12C Inhibitor. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Acquired Resistance to KRAS G12C Inhibitor trial results

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations